Contribution of human uropontin to inhibition of calcium oxalate crystallization

被引:103
作者
Asplin, JR
Arsenault, D
Parks, JH
Coe, FL
Hoyer, JR
机构
[1] Univ Chicago, Nephrol Sect, Dept Med, Chicago, IL 60637 USA
[2] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA
关键词
calcium oxalate crystallization; uropontin; stone formation; nephrolithiasis;
D O I
10.1046/j.1523-1755.1998.00739.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Uropontin (UP) is known to inhibit the growth and nucleation of calcium oxalate monohydrate (COM) crystals, and it also impedes attachment of calcium oxalate crystals to cultured renal epithelial cells. However, its role in normal defense against renal crystallization, and in pathogenesis of nephrolithiasis is unclear. In this study we determined the effect of UP on aggregation of COM crystals as well as the inhibitory activity of UP on COM crystal growth and nucleation in a series of normal subjects, in order to assess the potential of UP as an important urinary inhibitor. The mean urinary excretion of UP measured by ELISA was 185 +/- 12 nmol/24 hr (mean +/- SEM) with a mean urine UP concentration of 131 +/- 13 nM. Uropontin isolated by immunoaffinity chromatography was a very potent inhibitor of COM crystal aggregation, with a mean UP concentration of 28 +/- 4 nM required for a 50% reduction in aggregation. The kDa for COM crystal growth inhibition determined from Langmuir type isotherms was 21 +/- 3 nM and the concentration required for 50% reduction in COM crystal growth rate was 16 +/- 2 nM. Inhibition of secondary nucleation was measured at a single concentration of 200 nM, which reduced the nucleation rate to 42 +/- 3% of control. Using a theoretical model of growth and aggregation inhibition at varying urine flow rates, we showed that inhibitory activity of UP would be significant for all subjects over a wide range of urine flow rates. Overall, UP is a potent inhibitor of COM aggregation as well as growth and nucleation. The urinary concentration of UP is in the range in which its contribution to inhibition of growth and aggregation are likely to be substantial. Thus, UP appears to be an important natural defense against renal crystallizations and nephrolithiasis.
引用
收藏
页码:194 / 199
页数:6
相关论文
共 21 条
[1]   EVIDENCE THAT NEPHROCALCIN AND URINE INHIBIT NUCLEATION OF CALCIUM-OXALATE MONOHYDRATE CRYSTALS [J].
ASPLIN, J ;
DEGANELLO, S ;
NAKAGAWA, YN ;
COE, FL .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (05) :F824-F830
[2]   CHARACTERIZATION OF URONIC ACID-RICH INHIBITOR OF CALCIUM-OXALATE CRYSTALLIZATION ISOLATED FROM RAT URINE [J].
ATMANI, F ;
KHAN, SR .
UROLOGICAL RESEARCH, 1995, 23 (02) :95-101
[3]  
CHALKO C, 1993, J AM SOC NEPHROL, V4, P68
[4]   MEDICAL PROGRESS - THE PATHOGENESIS AND TREATMENT OF KIDNEY-STONES [J].
COE, FL ;
PARKS, JH ;
ASPLIN, JR .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (16) :1141-1152
[5]  
Coe FL, 1992, DISORDERS BONE MINER, P757
[6]   CALCIUM-OXALATE CRYSTAL MATRIX EXTRACT - THE MOST POTENT MACROMOLECULAR INHIBITOR OF CRYSTAL-GROWTH AND AGGREGATION YET TESTED IN UNDILUTED HUMAN URINE IN-VITRO [J].
DOYLE, IR ;
MARSHALL, VR ;
DAWSON, CJ ;
RYALL, RL .
UROLOGICAL RESEARCH, 1995, 23 (01) :53-62
[7]  
FREIFELDER D, PHYSICAL BIOCH
[8]   MOLECULAR ABNORMALITY OF TAMM-HORSFALL GLYCOPROTEIN IN CALCIUM-OXALATE NEPHROLITHIASIS [J].
HESS, B ;
NAKAGAWA, Y ;
PARKS, JH ;
COE, FL .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (04) :F569-F578
[9]   INHIBITION OF CALCIUM-OXALATE MONOHYDRATE CRYSTAL AGGREGATION BY URINE PROTEINS [J].
HESS, B ;
NAKAGAWA, Y ;
COE, FL .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (01) :F99-F106
[10]   ACIDIC PEPTIDE AND POLYRIBONUCLEOTIDE CRYSTAL-GROWTH INHIBITORS IN HUMAN URINE [J].
ITO, H ;
COE, FL .
AMERICAN JOURNAL OF PHYSIOLOGY, 1977, 233 (05) :F455-F463